ADPT Sale Disclosure
Robins Harlan S · SEC Form 4 · Filed Jul 23, 2026
Sale
Calculated transaction value
$6.05M
Robins Harlan S Chief Scientific Officer
Transaction date
Jul 21, 2026
Public filing date
Jul 23, 2026
Filing lag
Filed 2 days later
ADPT daily price context
Close on/before transaction
$22.58
Jul 21, 2026
Close before public filing
$21.95
Jul 22, 2026
Return since public filing
+10.62%
Through Sep 4, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 278,698 shares @ $21.72
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001780851-26-000017
Filing cohort
Transactions in this filing
Showing 4 of 4
Trades
4
Issuers
1
Estimated value
$12.65M
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Adaptive Biotechnologies Corp ADPT Current | Sale | Jul 21, 2026 | $6.05M |
| Adaptive Biotechnologies Corp ADPT | Sale | Jul 21, 2026 | $4.73M |
| Adaptive Biotechnologies Corp ADPT | Exercise | Jul 21, 2026 | $1.87M |
| Adaptive Biotechnologies Corp ADPT | Exercise | Jul 21, 2026 | $0 |